Stay updated on Re-sensitizing Carboplatin-Resistant Ovarian Cancer: FAK Clinical Trial
Sign up to get notified when there's something new on the Re-sensitizing Carboplatin-Resistant Ovarian Cancer: FAK Clinical Trial page.

Latest updates to the Re-sensitizing Carboplatin-Resistant Ovarian Cancer: FAK Clinical Trial page
- CheckyesterdayChange DetectedAdds new quick-access sections for joining and contacting the study (Check who can join, How to Join a Study, Find Contact Information) and guidance pages (How to Read a Study Record, Common Questions), plus a site revision note (Revision: v3.6.0). Removes an older Interventions/Treatment heading with different formatting and trims out some topic tags (Ovarian cancer, MedlinePlus Genetics) to streamline the page.SummaryDifference0.6%

- Check8 days agoChange DetectedOvarian cancer is added as a related topic and MedlinePlus Genetics is listed under related topics. The page shows a new revision line: Revision: v3.5.5.SummaryDifference0.2%

- Check15 days agoNo Change Detected
- Check22 days agoNo Change Detected
- Check30 days agoChange DetectedA new revision tag Revision: v3.5.4 was added and the previous tag Revision: v3.5.3 was removed. This indicates an administrative update to the study record rather than a change to the study content.SummaryDifference0.1%

- Check44 days agoChange DetectedRemoved the related topics entries for 'Ovarian cancer' and 'MedlinePlus Genetics' from the page's related topics section. This changes the related-topic suggestions shown to users but does not affect the study data or eligibility.SummaryDifference0.2%

- Check51 days agoChange DetectedThis updates the site’s displayed revision/version number from v3.5.2 to v3.5.3, reflecting a minor platform release rather than a change to the study record content.SummaryDifference0.1%

- Check58 days agoChange DetectedPage revision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

Stay in the know with updates to Re-sensitizing Carboplatin-Resistant Ovarian Cancer: FAK Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Re-sensitizing Carboplatin-Resistant Ovarian Cancer: FAK Clinical Trial page.